Latest Earnings Analysis
-
Installed Building Products (IBP) Q4 2025: Heavy Commercial Sales Jump 38%, Offsetting Residential Weakness
February 26, 2026 · IBP
-
GeoPark (GPRK) Q4 2025: Frontera Acquisition Set to Double Reserves, Scaling 2028 Production Path
February 26, 2026 · GPRK
-
International Seaways (INSW) Q4 2025: Dividend Payout Ratio Climbs to 87% Amid Fleet Renewal and Tight Tanker Supply
February 26, 2026 · INSW
-
Chiron Real Estate (GMRE) Q4 2025: $250M Disposition Pipeline Fuels Shift Into Senior Housing Growth
February 26, 2026 · GMRE
-
SM Energy (SM) Q4 2025: $185M Synergy Capture and 14% CapEx Cut Signal Capital Efficiency Pivot
February 26, 2026 · SM
-
Perimeter Solutions (PRM) Q4 2025: MMT Adds $140M Revenue, Accelerating Portfolio Diversification
February 26, 2026 · PRM
-
Lindblad Expeditions (LIND) Q4 2025: Net Yield Climbs 14% as Booking Curve Extends, Unlocking Margin Upside
February 26, 2026 · LIND
-
Vericel (VCEL) Q4 2025: Macy Franchise Grows 23% as Expanded Sales Force and Arthro Adoption Accelerate Penetration
February 26, 2026 · VCEL
-
Chimera Therapeutics (KYMR) Q4 2025: $1.6B Cash Extends Runway, KT621 Drives Paradigm Shift in Type 2 Disease
February 26, 2026 · KYMR
-
CIBC (CM) Q1 2026: Operating Leverage Hits 3.6% as Diversified Revenue Powers 10th Straight Win
February 26, 2026 · CM
-
Payoneer (PAYO) Q4 2025: B2B Revenue Jumps 28%, Upmarket Shift Accelerates Margin Expansion
February 26, 2026 · PAYO
-
PLDT (PHI) Q4 2025: Fiber Net Adds Surge 98% as Data Center and Digital Drive Margin Stability
February 26, 2026 · PHI
-
Bristow Group (VTOL) Q4 2025: 25% Contract Rate Uplift Drives Offshore Segment Repricing
February 26, 2026 · VTOL
-
GoodRx (GDRX) Q4 2025: PharmaDirect Revenue Jumps 41% as Platform Shifts to Manufacturer Partnerships
February 26, 2026 · GDRX
-
Accelerate Energy (EE) Q4 2025: Iraq Project Lifts 2026 EBITDA Outlook by $80M as Regasification Wave Builds
February 26, 2026 · EE
-
Montrose Environmental (MEG) Q4 2025: Cross-Sell Revenue Jumps to 62%, Signaling Deepening Client Penetration
February 26, 2026 · MEG
-
Wave Life Sciences (WVE) Q4 2025: R&D Spend Rises 15% as Obesity and RNA Editing Pipeline Accelerates
February 26, 2026 · WVE
-
Teleflex (TFX) Q4 2025: $1.8B Divestiture Proceeds Set Up 2027 EPS Surge
February 26, 2026 · TFX
-
Chesapeake Utilities (CPK) Q4 2025: CapEx Surges 32%, Fueling Record Margin Expansion
February 26, 2026 · CPK
-
VYX Q4 2025: Platform Sites Up 8% as Backlog Becomes Core Growth Signal
February 26, 2026 · VYX
-
VSE (VSEC) Q4 2025: Aviation Margins Expand 260bps as Pure-Play Transformation Accelerates
February 26, 2026 · VSEC
-
ZLAB Q4 2025: Pipeline Drives 17% Revenue Growth, Sets Stage for 2026 Launches
February 26, 2026 · ZLAB
-
Vital Farms (VITL) Q4 2025: $100M Share Buyback and 25% Revenue Growth Signal Aggressive Capacity Bet
February 26, 2026 · VITL
-
TWFG (TWFG) Q4 2025: Corporate Branch Margins Hit 35% as Tech Investment Drives Productivity
February 26, 2026 · TWFG
-
PNTG Q4 2025: Southeast Expansion Targets Double-Digit Margin Run Rate
February 26, 2026 · PNTG
-
Ligand (LGND) Q4 2025: Royalty Revenue Jumps 48% as Portfolio Drives $1B Deployable Capital
February 26, 2026 · LGND
-
Acushnet (GOLF) Q4 2025: $70M Tariff Headwind Caps Margin Expansion Even as Equipment Surges
February 26, 2026 · GOLF
-
DQ Q4 2025: EBITDA Swings $389M as Polysilicon Cost Cuts and Policy Intervention Reset Industry Structure
February 26, 2026 · DQ
-
LNTH Q4 2025: NeuroSeq Triples Growth as Lantheus Refocuses on Diagnostics
February 26, 2026 · LNTH
-
Shift4 (FOUR) Q4 2025: GlobalBlue Drives 46% GRLNF Growth, International Expansion Accelerates
February 26, 2026 · FOUR
-
Walker & Dunlop (WD) Q4 2025: Transaction Volumes Surge 161% as Portfolio Resets Set Stage for 2026
February 26, 2026 · WD
-
Viatris (VTRS) Q4 2025: $650M Cost Overhaul Sets Stage for Sustainable Margin Expansion
February 26, 2026 · VTRS
-
Dorman Products (DORM) Q4 2025: Tariff-Driven $1.25 EPS Swing Shapes 2026 Margin Trajectory
February 26, 2026 · DORM
-
Global Net Lease (GNL) Q4 2025: $2.8B Debt Reduction Unlocks Strategic Flexibility
February 26, 2026 · GNL
-
KBR (KBR) Q4 2025: Backlog Climbs 15% as OPEX Expansion and Defense Wins Drive Visibility
February 26, 2026 · KBR
-
ACI Worldwide (ACIW) Q4 2025: Kinetic Pipeline Drives Double-Digit Growth and Expanding Margins
February 26, 2026 · ACIW
-
Certara (CERT) Q4 2025: Software Revenue Up 10% as Execution Focus Sharpens for 2026
February 26, 2026 · CERT
-
Stantec (STN) Q4 2025: Backlog Climbs 9.5% to $8.6B, Securing Multi-Sector Growth Visibility
February 26, 2026 · STN
-
Primo Brands (PRMB) Q4 2025: Premium Brands Jump 44% as Margin Expansion Outpaces Sales Recovery
February 26, 2026 · PRMB
-
FTAI (FTAI) Q4 2025: SCI Fund Deploys $6B, Power Platform Ramps Toward 100-Unit Target
February 26, 2026 · FTAI
-
APA (APA) Q4 2025: Cost Base Cut by $450M Run Rate, Unlocks Decade-Long Permian Visibility
February 26, 2026 · APA
-
KOP Q4 2025: PC Margin Expands 370bps, Utility Pole Acquisitions Secure Supply Chain
February 26, 2026 · KOP
-
Celsius (CELH) Q4 2025: Alani New Drives 136% Growth, Doubling Portfolio Shelf Space
February 26, 2026 · CELH
-
NovaCure (NVCR) Q4 2025: Non-GBM Portfolio Targets $25M as Platform Expansion Accelerates
February 26, 2026 · NVCR
-
Hudson Pacific Properties (HPP) Q4 2025: $330M Asset Sales Reset Balance Sheet, Sets Up for Occupancy-Driven NOI Growth
February 26, 2026 · HPP
-
Summit Hotel Properties (INN) Q4 2025: Asset Sales Unlock $200M as RevPAR Headwinds Ease
February 26, 2026 · INN
-
Nexstar (NXST) Q4 2025: Digital Revenue Set to Surpass National TV, Bolstering Growth Trajectory
February 26, 2026 · NXST
-
BioCryst (BCRX) Q4 2025: Orladeyo Revenue Jumps 43% as HAE Franchise Deepens Portfolio
February 26, 2026 · BCRX
-
Burford Capital (BUR) Q4 2025: Definitive Commitments Jump 39%, Portfolio Expansion Outpaces Realizations
February 26, 2026 · BUR
-
Gildan (GIL) Q4 2025: Synergy Target Raised to $250M as Hanes Integration Accelerates
February 26, 2026 · GIL